Host genetic determinants of Neisseria meningitidis infections

The clinical presentation of infections caused by Neisseria meningitidis is highly diverse. Some patients develop meningitis, and others present with sepsis or even septic shock. After invasion of the bloodstream by the bacteria, three main cascade pathways are activated. These are the complement sy...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet infectious diseases Vol. 3; no. 9; pp. 565 - 577
Main Authors Emonts, M, Hazelzet, JA, de Groot, R, Hermans, PWM
Format Journal Article
LanguageEnglish
Published United States Elsevier Ltd 01.09.2003
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The clinical presentation of infections caused by Neisseria meningitidis is highly diverse. Some patients develop meningitis, and others present with sepsis or even septic shock. After invasion of the bloodstream by the bacteria, three main cascade pathways are activated. These are the complement system, the inflammatory response, and the coagulation and fibrinolysis pathway. These pathways do not act independently but are able to interact with each other. Genetic polymorphisms among components of these pathways have been shown to be involved in the susceptibility, severity, and outcome of meningococcal disease. We review knowledge of genetic variations associated with susceptibility to and severity of meningococcal infection. Complement deficiencies and defects in sensing or opsonophagocytic pathways, such as the rare Toll-like receptor 4 single nucleotide polymorphisms (SNPs) and combinations of inefficient variants of Fcγ-receptors, seem to have the most important role in genetically established susceptibility. Effect on severity has repeatedly been reported for FcγRIIa and plasminogen activator inhibitor type 1 (PAI1) polymorphisms. Outcome effects have been confirmed for SNPs in properdin deficiencies, PAI1 and combination of the −511C/T SNP in interleukin 1β, and the +2018C/T SNP in interleukin RN. Conflicting results are reported for the effect of the −308G/A promoter polymorphism in tumour necrosis factor (TNF) α. These differences may reflect discrepancies in group definitions between studies or the influence of additional SNPs in the TNFα promoter, which can form haplotypes representing different cytokine production capacity. For several SNPs, the potential effect on susceptibility, severity, or outcome has not yet been confirmed in an independent study.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ObjectType-Feature-3
ObjectType-Review-1
ISSN:1473-3099
1474-4457
DOI:10.1016/S1473-3099(03)00740-0